image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 14 days, don't miss out!

Franchise Brands

January 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FRAN
  • Price:
  • 153p
Trading in Q3 and early in Q4 has continued earlier  trends with trading in line with expectations (EBITDA range £35.7m-£37m). At Pirtek Europe (acquired April 2023), demand for essential reactive services remains resilient even though project work and other discretionary spending has been subdued reflecting a tough macro climate, particularly in the UK (pre Budget) and Germany where manufacturing PMI data has been below the 50 (no change) level since summer 2022. Integration has gone well with targeted cost savings achieved. The next stage is implementing the new IT platform to drive operational gearing.   Demand for the Waste and Water services and Filta (USA) businesses continues to be robust. The shares trade on ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe